Migraine study unlocks secrets of placebo vs. real drug effects
NCT ID NCT07071506
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to understand how the information given to patients about their treatment affects their response to migraine medication. Researchers will give 60 adults with chronic migraine four different treatment conditions in a random order and measure changes in headache intensity, number of headache days, and side effects. The goal is to improve how we evaluate preventive migraine treatments by separating the drug's effect from the placebo effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MIGRAINE HEADACHE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Neurology, Aarhus University Hospital
RECRUITINGAarhus N, Denmark, 8200, Denmark
-
Department of Psychology and Behavioral sciences, Aarhus BSS, Aarhus University
RECRUITINGAarhus C, Denmark, 8000, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a numbing nose treatment stop migraine pain in its tracks?
- Could blocking an extra nerve double migraine relief?
- Can migraine meds be safe while breastfeeding? a new study investigates
- Could a symptom registry unmask hidden migraine variants?
- Electric zaps to the brain may tame chronic migraine
- A migraine-blocking antibody tested in children as young as 6